A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer

DSpace Repository

Show simple item record

dc.contributor.author Kopp, Hans-Georg
dc.contributor.author Kimmich, Martin
dc.date.accessioned 2021-07-27T10:57:51Z
dc.date.available 2021-07-27T10:57:51Z
dc.date.issued 2021
dc.identifier.issn 1758-8359
dc.identifier.uri http://hdl.handle.net/10900/117335
dc.language.iso en de_DE
dc.publisher Sage Publications Ltd de_DE
dc.relation.uri http://dx.doi.org/10.1177/1758835921996506 de_DE
dc.subject.ddc 610 de_DE
dc.title A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer de_DE
dc.type Artikel de_DE
utue.quellen.id 20210512015105_00581
utue.personen.roh Metzenmacher, Martin
utue.personen.roh Kopp, Hans-Georg
utue.personen.roh Griesinger, Frank
utue.personen.roh Reinmuth, Niels
utue.personen.roh Sebastian, Martin
utue.personen.roh Serke, Monika
utue.personen.roh Waller, Cornelius Florian
utue.personen.roh Thomas, Michael
utue.personen.roh Eggert, Jochen
utue.personen.roh Schmid-Bindert, Gerald
utue.personen.roh Hoiczyk, Mathias
utue.personen.roh Christoph, Daniel Christian
utue.personen.roh Kimmich, Martin
utue.personen.roh Deuss, Burkhard
utue.personen.roh Seifert, Stephanie
utue.personen.roh Held, Swantje
utue.personen.roh Schuler, Martin
utue.personen.roh Herold, Thomas
utue.personen.roh Breitenbuecher, Frank
utue.personen.roh Eberhardt, Wilfried Ernst Erich
dcterms.isPartOf.ZSTitelID Therapeutic Advances in Medical Oncology de_DE
dcterms.isPartOf.ZS-Issue Article 1758835921996506 de_DE
dcterms.isPartOf.ZS-Volume 13 de_DE
utue.fakultaet 04 Medizinische Fakultät de_DE


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record